病态呼吸道化学反射激活预测神经认知功能的改善,以应对持续的正气道压力治疗
Yu-Tong Hu1,2, Yue-Nan Ni1,2, Hugi Hilmisson3
1Department of Respiratory, Critical Care and Sleep Medicine, West China School of Medicine and West China Hospital, Sichuan University, Chengdu, China.
Frontiers in neuroscience
|October 10, 2025
概括
升高的低频窄带 (e-LFCNB%) 可能预测CPAP治疗的阻塞性睡眠呼吸暂停 (OSA) 患者的神经认知改善. 这种生物标志物对个性化OSA治疗和改善患者的治疗结果充满希望.
科学领域:
- 睡眠医学 睡眠医学
- 神经科学是一个神经科学.
- 生物标志物发现发现
背景情况:
- 阻塞性睡眠呼吸暂停 (OSA) 对神经认知功能产生负面影响.
- 持续正气道压力 (CPAP) 是一种标准的OSA治疗方法,但治疗反应各不相同.
- 需要CPAP后神经认知改善的预测生物标志物.
研究的目的:
- 调查高循环增益生物标志物 (e-LFCNB%) 与OSA患者神经认知功能改善之间的关联.
- 为了确定e-LFCNB%是否可以预测无呼吸正压长期疗效研究 (APPLES) 中的治疗反应.
主要方法:
- e-LFCNB%是从接受CPAP的362名OSA患者的基线多眠学数据计算出来的.
- 后勤回归分析评估了e-LFCNB%和2个月和6个月的认知改善之间的相关性.
主要成果:
- 较高的e-LFCNB%水平与2个月和6个月的工作记忆 (SWMT-OMD) 的显著改善相关 (p<0.05).
- 升高的e-LFCNB%也预测了2个月CPAP后更好的回忆得分 (BSRT-SR) (p=0.041).
- 在Pathfinder Number Test (PFN-TOTL) 中没有发现显著的关联.
结论:
- 显示可能的高循环收益的e-LFCNB%指标可能作为CPAP治疗后认知增强的有价值的临床预测指标.
- 这一发现支持使用睡眠呼吸暂停内型来个性化OSA治疗策略的潜力.
相关概念视频
Chemical Factors Affecting Respiration Centers
2.1K
Chemical factors such as changing CO2, O2, and H+ levels in arterial blood play a critical role in influencing respiration depth and rates. These variations are detected by chemoreceptors—specialized sensors located in two primary body areas. Central chemoreceptors are found throughout the brain stem, including the ventrolateral medulla, while peripheral chemoreceptors are located in the aortic arch and carotid arteries.
CO2 has a potent influence on respiration and is strictly regulated....
CO2 has a potent influence on respiration and is strictly regulated....
2.1K
Physiological Control of Respiration
5.8K
Introduction
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
5.8K
Physiology of Respiration II: Neurogenic Control of Respiration
1.9K
The neurogenic control of respiration coordinates various neural networks and pathways to regulate breathing rate and depth, meeting the body's oxygen and carbon dioxide exchange requirements. This system adapts to physiological and environmental conditions, ensuring optimal breathing patterns.
Central Control
The brainstem is the primary site of central control, hosting respiratory centers:
Central Control
The brainstem is the primary site of central control, hosting respiratory centers:
1.9K
Acute Respiratory Failure-IV
510
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
510
Acute Respiratory Failure-V
455
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
455
Acute Respiratory Failure-III
781
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
781


